Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 7/20 | 0.41 |
| ▸ | MASP2 | O00187 | 6/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | F2 | P00734 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | ACACA | Q13085 | 3/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7774712 | 0.90 | CACNA1B (0.38) | ACACBMASP2F2CACNA1B | |
| SCHEMBL7108120 | 0.85 | HTR2C (0.42) | — | |
| SCHEMBL7109533 | 0.83 | CACNA1B (0.38) | ACACBMASP2F2CACNA1B | |
| SCHEMBL6399627 | 0.83 | EPHX2 (0.37) | ACACBF2 | |
| SCHEMBL7107053 | 0.81 | CACNA1B (0.45) | ACACBKMT2AACACACACNA1BMEN1 | |
| SCHEMBL7107079 | 0.80 | NPC1 (0.39) | KMT2AMEN1 | |
| SCHEMBL7109567 | 0.80 | CTSC (0.33) | ACACBMASP2KMT2AF2 | |
| SCHEMBL7111677 | 0.76 | NPY5R (0.36) | ACACBCACNA1B | |
| SCHEMBL7109633 | 0.76 | EPHX2 (0.37) | ACACBMASP2 | |
| SCHEMBL5355003 | 0.74 | CACNA1B (0.54) | ACACBMASP2KMT2AF2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2003-01-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | CACNA1B, SCN1A, SCN2A | ACACB 1823/4885MASP2 4866/4885KMT2A 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.